-+ 0.00%
-+ 0.00%
-+ 0.00%

VIKING THERAPEUTICS, - PROCEEDS TO FUND VK2735, VK3019 CLINICAL DEVELOPMENT AND GENERAL CORPORATE PURPOSES

Reuters·09/23/2026 20:35:08